Because of effective antiretroviral therapy (ART), many people with HIV will live a normal or near-normal lifespan.
1 Management of HIV continues to improve, with increasing options for initial therapy, novel approaches for switching therapy, and effective strategies for managing co-infections. In addition, there are new tools for preventing cardiovascular disease in people with HIV and for reducing the incidence of sexually transmitted infections (STIs). HIV prevention through preexposure prophylaxis (PrEP) remains a dynamic field, with several recent advances. However, improving care of people with HIV who have substance use disorder (SUD) and addressing HIV care disparities remain challenges and high priorities. Here, updated recommendations for HIV treatment and clinical management as well as HIV prevention based on the latest data are provided, and challenges that need additional attention and dedicated resources are highlighted.